PRKD1 and breast carcinoma: In addition, dysregulation of PKD expression or activity has been described to contribute to the development and progression of various malignancies, including breast cancer, pancreatic cancer and prostate cancer [19,29,30,31,32,33,34,35,36,37,38,39,40,41,42,43].